|
PLAA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.98594482472936E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.62123656113999E-12 |
| Normal-vs-Stage2 |
1.53610000053206E-07 |
| Normal-vs-Stage3 |
6.15459999999679E-05 |
| Normal-vs-Stage4 |
1.51269999999482E-05 |
| Stage1-vs-Stage2 |
6.371400E-01 |
| Stage1-vs-Stage3 |
4.184200E-01 |
| Stage1-vs-Stage4 |
9.415200E-01 |
| Stage2-vs-Stage3 |
7.255200E-01 |
| Stage2-vs-Stage4 |
7.004800E-01 |
| Stage3-vs-Stage4 |
5.669000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28674848554056E-13 |
| Normal-vs-AfricanAmerican |
1.17859999981818E-07 |
| Normal-vs-Asian |
1.689170E-01 |
| Caucasian-vs-AfricanAmerican |
1.189160E-01 |
| Caucasian-vs-Asian |
4.243000E-01 |
| AfricanAmerican-vs-Asian |
8.291400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65667479734566E-12 |
| Normal-vs-Female |
1.87774999999002E-05 |
| Male-vs-Female |
2.362700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.19959999997666E-06 |
| Normal-vs-Extreme_Weight |
1.63502544836547E-12 |
| Normal-vs-Obese |
1.70849999703293E-08 |
| Normal-vs-Extreme_Obese |
1.047950E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.573600E-02 |
| Normal_Weight-vs-Obese |
9.408800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.614600E-01 |
| Extreme_Weight-vs-Obese |
4.120200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.860400E-01 |
| Obese-vs-Extreme_Obese |
6.433800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.155600E-04 |
| Normal-vs-Age(41-60Yrs) |
4.77929917863662E-11 |
| Normal-vs-Age(61-80Yrs) |
4.05675493198032E-13 |
| Normal-vs-Age(81-100Yrs) |
1.00400000535572E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.889800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.008800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.094750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.480800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.352200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.633000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62680979798324E-12 |
| Normal-VS-Type2 PRCC |
2.34300000001575E-06 |
| Normal-VS-KIRP CIMP |
1.920210E-02 |
| Normal-VS-Unclassified PRCC |
1.46610000029135E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.604260E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.759200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.528980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.542400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.042200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.294250E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51220036492816E-10 |
| Normal-vs-N1 |
2.34789999999929E-05 |
| Normal-vs-N2 |
2.13159999999935E-05 |
| N0-vs-N1 |
3.139600E-01 |
| N0-vs-N2 |
5.494200E-01 |
| N1-vs-N2 |
2.595000E-01 |
|
|
